Phibro Animal Health Co. (NASDAQ:PAHC) Receives $15.00 Average PT from Analysts

Shares of Phibro Animal Health Co. (NASDAQ:PAHC) have been given an average recommendation of “Strong Sell” by the five analysts that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating and two have issued a hold rating on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $15.00.

A number of analysts have recently weighed in on PAHC shares. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target for the company. Bank of America upped their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th.

Insider Activity at Phibro Animal Health

In other news, Director E Thomas Corcoran purchased 5,000 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were acquired at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the acquisition, the director now owns 25,000 shares in the company, valued at approximately $500,500. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 50.07% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Illinois Municipal Retirement Fund lifted its position in Phibro Animal Health by 7.2% in the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after acquiring an additional 765 shares in the last quarter. CWM LLC lifted its holdings in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after purchasing an additional 1,035 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Phibro Animal Health by 7.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after buying an additional 1,063 shares during the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after buying an additional 1,522 shares in the last quarter. Finally, Cardinal Capital Management raised its position in Phibro Animal Health by 4.7% in the 2nd quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock valued at $940,000 after buying an additional 2,520 shares during the last quarter. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Stock Up 0.3 %

Phibro Animal Health stock opened at $23.18 on Wednesday. Phibro Animal Health has a twelve month low of $9.40 and a twelve month high of $25.11. The stock has a market cap of $938.79 million, a P/E ratio of 386.40, a P/E/G ratio of 0.58 and a beta of 0.52. The company’s 50-day moving average price is $22.17 and its two-hundred day moving average price is $18.99. The company has a quick ratio of 1.64, a current ratio of 2.94 and a debt-to-equity ratio of 1.79.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. The business had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. As a group, analysts expect that Phibro Animal Health will post 1.57 EPS for the current year.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.